Nabilone may be “a safer and more effective treatment” for serious Alzheimer’s symptoms, according to an article in Contemporary Clinical Trials Communications, published in Science Direct.
The study found that Nabilone could reduce aggression, anxiety, depression and psychosis, said the article. It may also curb weight and protect the brain.
The randomized, double-blind, placebo-controlled clinical trial began in 2015 and was completed in April 2019.
It was sponsored by Sunnybrook Research Institute in Toronto, Ontario, Canada.